Background: A significant minority of Australians engage in concurrent drug use (using more
INTRODUCTION
Concurrent use (here defined as the use of more than one drug in a specified period, typically 1-12 months) is highly prevalent in young adulthood (Carter et al., 2013; Chen, Yi, & Moss, 2013; Chiauzzi, DasMahapatra, & Black, 2013; Chung, Kim, Hipwell, & Stepp, 2013; Font-Mayolas et al., 2013; Reyes, Perez, Colon, Dowell, & Cumsille, 2013; White et al., 2013) . When drugs are combined, there are risks of cumulative and synergistic effects on brain function (Connor, Gullo, White, & Kelly, 2014; Licata & Renshaw, 2010) and mental health problems (Quek et al., 2013; Smith, Farrell, Bunting, Houston, & Shevlin, 2011; White et al., 2013) . In an analysis of the 2007 national survey data (AIHW, 2008) , we examined the extent to which a nationally representative sample young adults aged 18-29 years used different combinations of alcohol, tobacco, and other drugs. We established five clusters of substance use: the majority of young adults predominantly used alcohol only (52.3%), or alcohol and tobacco (34.2%). The other classes were cannabis, ecstasy, and licit drug use (9.4%), cannabis, amphetamine derivative, and licit drug use (2.8%), and sedative and alcohol use (1.3%).
In this paper we replicated this analysis for the 2010 national survey data (AIHW, 2011) to assess the robustness of drug use clusters, and whether there had been changes from 2007 to 2010 in patterns and correlates of concurrent drug use. As in our analysis of the 2007 data and related research (Carter et al., 2013; Chung et al., 2013; Smith et al., 2011) , we examined the use of one or more substances in the previous year. The use of this time frame means that proximity of the use of different substances is closer than studies that use lifetime prevalence data on polydrug use (Agrawal, Lynskey, Madden, Bucholz, & Heath, 2007; Connor et al., 2014; Lynskey et al., 2006; White et al., 2013) , and cell sizes for clusters are sufficiently large to permit analysis of predictors of cluster membership.
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MATERIAL AND METHODS

Sample
The sample consisted of 3836 participants in the 2010 National Drug Strategy Household Survey (AIHW, 2011) who were aged 18-29 years (42.3% male; mean age = 23.97; SD = 3.49). Of these, 335 (8.7%) were excluded due to non-response on any of the drug-related items and 26
were excluded because they reported completing the questionnaire in the presence of another person where the honesty of their answers may have been affected. These exclusion criteria were the same as those applied to 2007 NDSHS data.
Measures
The measures were identical to those applied in our prior study of 2007 data (Quek et al., 2013) .
Concurrent drug use was based on >1 drug used in the past year [alcohol/tobacco/marijuana/ ecstasy/tranquillisers or sleeping pills/cocaine/hallucinogens/meth or amphetamine/pain-killers or analgesics, for non-medical purposes in the last 12 months]. Responses for each drug were coded as 0 "No" and 1 "Yes". For the purposes of examining similarities across and within clusters, a range of potential covariates were measured. Covariates including in the analysis were: sex, couple relationship status (0 "Not partnered" and 1 "partnered"), high school completion (0 "completed", 1 "not completed"), income levels (0" $41600 or above", 1 "$13000-41599", 2 "$12999 or below", 3 "prefer not to say/ don't know"), language spoken at home (0 "English", 1 "non-English"), regionality (1 "major cities", 2 "inner regional", 3 "outer regional/ remote/ very remote") (ABS, 2009), and depressive symptoms measured by the Kessler 10 scale (Kessler et al., 2003) .
Survey Procedure
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Participants were from all Australian States and Territories, and were randomly selected using a stratified design based on statistical local area (AIHW, 2011) . Access to the survey data was approved by the Australian Social Science Data Archive and by the University of Queensland Human Research Ethics Committee.
Analysis
As per our analysis of 2007 data, Latent Class Analysis (LCA) was used to analyse drug use.
The number of classes was determined using: Bayesian Information Criteria ( All analyses were performed with Mplus 6.01 (Muthén & Muthén, 2011) .
RESULTS
A six-class solution attained the lowest value of AIC, a four-class solution attained the lowest value of BIC and a five-class solution attained the lowest value of SSABIC. Results from the LMR-LRT suggested that a four-class solution fitted the data significantly better than the threeclass solution and not significantly worse than a five-class solution. Simulation suggested that the performance SSABIC and LMR-LRT were better than other criteria in model selection
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Concurrent drug use in young adults 6 (Nylund, Asparouhov, & Muthén, 2007; Yang, 2006) . However, since these two statistics pointed to two different solutions, both were examined on the basis of interpretability and usefulness of the classification (Muthén & Muthén, 2000) . In the four-class solution, an extended range concurrent drug using class was identified. This group was further broken down into two sub-classes in the five class solution each with a very small prevalence estimates, namely, a class with very high probabilities of using all the drugs, and a class with a very high probability of using all alcohol, tobacco, marijuana and pain killers, and a moderate probability of using tranquilisers. A comparison of the participants in these two classes indicated that they had very similar demographic profiles. The four-class solution was chosen as the optimal solution as it yielded classifications that was clearly distinct and interpretable, and had adequate class sizes with high average posterior probabilities. Average posterior probabilities were over 0.80 for all classes.
Each of the four classes was described below using the probabilities of drugs use in the past 12 months (see and moderate probabilities of hallucinogens (0.47). Relative to the Alcohol only class, the following findings were significant covariates that predicted membership in the multiple concurrent drug using classes (see Table 1 ): being male (Class 2, p < .05, Class 3, p < .001, respectively), not completing high school (all classes, p < .05), not having a partner (all classes, p < .05), low income level (Class 3, p < .001), depressive symptoms (p < .001), and coming from an English speaking home (p < .001). Regionality was unrelated to cluster membership.
[
INSERT TABLE 1 ABOUT HERE] [INSERT FIGURE 1 ABOUT HERE]
DISCUSSION
The overall objective of this study was to examine drug use clusters, their prevalence and correlates using the latest available (2010) nationally representative survey data. A four cluster solution was the most robust and interpretable and the key risk markers of cluster membership were being male and not competing high school. Coming from a non-English speaking home and having a partner were protective markers. There were close parallels between the 2007 and the 2010 clusters -both the present study and our earlier study identified an alcohol only cluster, an alcohol and tobacco cluster, and a marijuana, ecstacy and other licit drug use cluster. Our earlier study found evidence of a distinct cluster alcohol and sedatives/tranquilisers. In the present study this cluster was not replicated. Instead, posterior probabilities for sedatives/tranquiliser use were high in the extended concurrent drug use cluster. In our earlier
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We were able to make cautious observations about the relative prevalence of drug clusters from 2007 to 2010, given the similarity of the clusters across surveys. There was some variation in the proportions of the sample that fell into each cluster, but variations across the two surveys were within measurement error. For alcohol only, the proportion was 50.9 ± 1.7% in 2010, and given that tobacco and alcohol are the leading contributors to drug-related public health costs (Collins & Lapsley, 2008; Kelly, 2012) . More research is needed on the extent to which alcohol consumption is a contextual antecedent to smoking in young adults (Kelly & Jackson-Carroll, 2007; Kelly et al., 2011) . Longitudinal research on the association of concurrent drug use and senior school noncompletion is needed. Screening and brief advice/counselling in settings such as employment services, trade schools and technical colleges may assist in reducing the apparent broadening of substance use profiles that occurs over the transition to young adulthood (Chen et al., 2013) .
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While replication of earlier found clusters points to the robustness of findings, we have previously noted the limitations of these surveys. Individuals with severe problems may be under-represented in this survey. The design is cross-sectional and so conclusions cannot be made about causality, progression, and sequencing. The study relies on self-report, although the confidential and anonymous nature of participation is likely to have reduced response bias.
Findings may vary with the frequency/severity of substance use, which was not assessed.
Reports of the use of different substances within the past year (the present measure) may be more likely to capture proximal use compared to lifetime prevalence rates, but the use of individual substances may be temporally or functionally unrelated.
.
Concurrent drug use in young adults 10 Notes. * p < .05; ** p < .01; *** p < .001.
Polydrug use in young adults 11 A C C E P T E D M A N U S C R I P T
ACCEPTED MANUSCRIPT
Polydrug use in young adults 12
Statement 1: Role of Funding Sources
This study was supported though internal funds and via Australian Research Council Project DP130102015 to ABK (first chief investigator). JPC is supported by a National Health and Medical Research Council of Australia Career Development Fellowship (APP1031909). These funding bodies had no role in the design, analysis or interpretation of the data. The data on which this study is based were collected as part of the National Drug Strategy Household Survey by the Australian Institute of Health and Welfare. The funding sponsors had no role in the study design, collection, analysis, or interpretation of data, writing the manuscript, and the decision to submit the manuscript for publication.
Statement 2: Contributors
A. B. Kelly wrote the first draft of the manuscript. G.C.K. Chan conducted the analyses. A. White assisted with manuscript preparation and coordination of analyses. J. B. Saunders provided comments on an earlier draft. P. J. Baker provided feedback on statistical design and results. J. P. Connor provided advice on research methodology and feedback on the manuscript.
Statement 3: Conflict of Interest
There are no conflicts of interest by any author.
